Impact BioMedical Inc. (IBO)
NYSEAMERICAN: IBO · Real-Time Price · USD
0.5050
+0.0156 (3.19%)
At close: Dec 31, 2025, 4:00 PM EST
0.5011
-0.0039 (-0.77%)
After-hours: Dec 31, 2025, 8:00 PM EST
Impact BioMedical Employees
Impact BioMedical had 2 employees as of December 31, 2024. The number of employees increased by 1 or 100.00% compared to the previous year.
Employees
2
Change (1Y)
1
Growth (1Y)
100.00%
Revenue / Employee
$12,500
Profits / Employee
-$22,095,500
Market Cap
52.83M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2 | 1 | 100.00% |
| Dec 31, 2023 | 1 | -1 | -50.00% |
| Dec 31, 2022 | 2 | 0 | - |
| Dec 31, 2021 | 2 | 0 | - |
| Dec 31, 2020 | 2 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
IBO News
- 4 months ago - Impact Biomedical Inc (IBO) Announces 3F™ US Patent Issue - GlobeNewsWire
- 6 months ago - Dr Ashleys Limited and Impact BioMedical Inc. Announce Strategic Merger - GlobeNewsWire
- 10 months ago - Impact Biomedical Inc. Announcement Stock Activity/Pricing - GlobeNewsWire
- 1 year ago - Impact BioMedical Inc. to Present at The Microcap Conference - GlobeNewsWire
- 1 year ago - Impact BioMedical Inc. Announces Issuance of Canadian Patent for Linebacker™ Technology Targeting Inflammatory Disease - GlobeNewsWire
- 1 year ago - Impact BioMedical Inc. (NYSE American: IBO) Announces IPO Participation with Strong Support from Partners and Affiliates - GlobeNewsWire
- 1 year ago - Impact BioMedical Inc. (NYSE: IBO) Announces 3F™ US Patent Issue - GlobeNewsWire
- 1 year ago - Impact BioMedical Inc. Announces the Closing of its Initial Public Offering - GlobeNewsWire